NIH develops AI tool to better pair cancer patients with drugs
The proof-of-concept study published in Nature Cancer highlights how researchers are using tumor cells to predict whether patients will respond to specific drugs.
Stay updated with breaking news from Bio Med. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The proof-of-concept study published in Nature Cancer highlights how researchers are using tumor cells to predict whether patients will respond to specific drugs.
TenAces will develop an AI platform to help identify protein interactions that naturally occur in the body to assist with targeted protein degradation.
Construction news, building, construction jobs, contract news, new work, equipment, civil engineering, business, built environment
The company will use the funds to grow its drug-discovery pipeline and clinical AI stack.
Construction news, building, construction jobs, contract news, new work, equipment, civil engineering, business, built environment